For decades, the gold standard for treating severe degenerative disc disease and chronic back pain was spinal fusion. While effective at stopping motion, fusion came with a significant trade-off: it transferred stress to adjacent vertebral segments, often leading to further degeneration down the line.
: Activation of clinical sites is currently underway across the United States. Comparison to Alternative Biologics
DiscGenics has launched DDDtrial.com to provide information and a pre-screening process for individuals interested in the Phase 3 study. diskgen intervertebral
The anatomical term is discus intervertebralis (intervertebral disc) — the fibrocartilaginous cushion between vertebrae in the spine. “Diskgen” might be a shorthand or typo for diskogenic (originating from the disc).
The success of any artificial disc lies in its biomimicry. The natural intervertebral disc is a complex structure consisting of a gel-like nucleus pulposus surrounded by tough fibrous rings (annulus fibrosus). For decades, the gold standard for treating severe
: Unlike palliative treatments that only mask pain, IDCT uses a proprietary population of live Discogenic Cells —progenitor cells derived from donated adult human disc tissue. These cells are injected into the degenerated disc to reduce inflammation and potentially restore disc structure from within.
Enter the age of motion preservation.
The field of intervertebral disc replacement is rapidly evolving. Future iterations of devices like DiskGen are looking toward "smart materials" that can better mimic the viscoelastic properties of natural tissue, and perhaps even 3D-printed implants customized to a patient’s specific anatomy.
The therapy is currently in late-stage clinical evaluation in the United States. The success of any artificial disc lies in its biomimicry
Example:
: A single, minimally invasive percutaneous injection performed in an outpatient setting under fluoroscopic guidance. Clinical Development Status (April 2026)